{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:50:28Z","timestamp":1765381828452},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T00:00:00Z","timestamp":1365552000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12032-013-0560-5","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T12:02:41Z","timestamp":1365508961000},"source":"Crossref","is-referenced-by-count":7,"title":["High CD74 expression correlates with ZAP70 expression in B cell chronic lymphocytic leukemia patients"],"prefix":"10.1007","volume":"30","author":[{"given":"Aleksandra","family":"Butrym","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslaw","family":"Majewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Dzietczenia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazimierz","family":"Kuliczkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,10]]},"reference":[{"key":"560_CR1","first-page":"1","volume-title":"History of chronic lymphocytic leukemia. Chronic lymphoid leukemias second edition","author":"KR Rai","year":"2001","unstructured":"Rai KR, Wasil T. History of chronic lymphocytic leukemia. Chronic lymphoid leukemias second edition. New York: National Cancer Institiute; 2001. p. 1\u20137."},{"key":"560_CR2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1182\/blood-2009-08-207126","volume":"115","author":"JG Gribben","year":"2010","unstructured":"Gribben JG. How I treat CLL up front. Blood. 2010;115:187\u201397.","journal-title":"Blood"},{"key":"560_CR3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1586\/era.12.2","volume":"12","author":"A Bazargan","year":"2012","unstructured":"Bazargan A, Tam CS, Keating MJ. Predicting survival of chronic lymphocytic leukemia. Expert Rev Anticancer Ther. 2012;12:393\u2013403.","journal-title":"Expert Rev Anticancer Ther"},{"key":"560_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc2764","volume":"10","author":"T Zenz","year":"2010","unstructured":"Zenz T, Mertens D, K\u00fcppers R, D\u00f6hner H, Stilgenbauer S. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev. 2010;10:37\u201350.","journal-title":"Nat Rev"},{"key":"560_CR5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0145-2126(03)00023-7","volume":"27","author":"RS Houlston","year":"2003","unstructured":"Houlston RS, Sellick G, Yuille M, Matutes E, Catovsky D. Causation of chronic lymphocytic leukemia\u2013insights from familial disease. Leuk Res. 2003;27:871\u20136.","journal-title":"Leuk Res"},{"key":"560_CR6","doi-asserted-by":"crossref","first-page":"5556s","DOI":"10.1158\/1078-0432.CCR-07-1167","volume":"13","author":"R Stein","year":"2007","unstructured":"Stein R, Mattes MJ, Cardillo TM, et al. CD74: a new candidate target for the immunotherapy of B-cell neoplasms. Clin Cancer Res. 2007;13:5556s\u201363s.","journal-title":"Clin Cancer Res"},{"key":"560_CR7","doi-asserted-by":"crossref","first-page":"27203","DOI":"10.1074\/jbc.M104684200","volume":"276","author":"D Matza","year":"2001","unstructured":"Matza D, Wolstein O, Dikstein R, Schachar I. Invariant chain induces B cell maturation by activating a TAFII105-NF- \u03baB-dependent transcription program. J Biol Chem. 2001;276:27203\u20136.","journal-title":"J Biol Chem"},{"key":"560_CR8","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3109\/10428194.2011.565437","volume":"52","author":"I Shachar","year":"2011","unstructured":"Shachar I, Haran M. The secret second life of an innocent chaperone: the story of CD74 and B cell\/chronic lymphocytic leukemia cell survival. Leuk Lymphoma. 2011;52:1446\u201354.","journal-title":"Leuk Lymphoma"},{"key":"560_CR9","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1084\/jem.20030286","volume":"197","author":"L Leng","year":"2003","unstructured":"Leng L, Metz CN, Fang Y, et al. MIF signal transduction initiated by binding to CD74. J Exp Med. 2003;197:1467\u201376.","journal-title":"J Exp Med"},{"key":"560_CR10","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.3748\/wjg.15.5541","volume":"15","author":"GQ Li","year":"2009","unstructured":"Li GQ, Xie J, Lei XY, Zhang L. Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3\u00a0K\/Akt pathway. World J Gastroenterol. 2009;15:5541\u20138.","journal-title":"World J Gastroenterol"},{"key":"560_CR11","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1158\/1078-0432.CCR-04-0182","volume":"10","author":"JD Burton","year":"2004","unstructured":"Burton JD, Ely S, Reddy PK, et al. CD74 is expressed by multiple myeloma cells and is promising target for therapy. Clin Cancer Res. 2004;10:6606\u201311.","journal-title":"Clin Cancer Res"},{"key":"560_CR12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3835(01)00503-1","volume":"168","author":"S Ishigami","year":"2001","unstructured":"Ishigami S, Natsugoe S, Tokuda K, et al. Invariant chain expression in gastric cancer. Cancer Lett. 2001;168:87\u201391.","journal-title":"Cancer Lett"},{"key":"560_CR13","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0002-9440(10)64120-X","volume":"158","author":"AN Young","year":"2001","unstructured":"Young AN, Amin MB, Moreno CS, et al. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol. 2001;158:1639\u201351.","journal-title":"Am J Pathol"},{"key":"560_CR14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2353\/ajpath.2009.080463","volume":"174","author":"M McClelland","year":"2009","unstructured":"McClelland M, Zhao L, Carskadon S, Arenberg D. Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer. Am J Pathol. 2009;174:638\u201346.","journal-title":"Am J Pathol"},{"key":"560_CR15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00022744-200009000-00007","volume":"8","author":"MW Datta","year":"2000","unstructured":"Datta MW, Shahsafaei A, Nadler LM, Freeman GJ, Dorfman DM. Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms. Appl Immunohistochem Mol Morphol. 2000;8:210\u20135.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"560_CR16","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2115::AID-CNCR8>3.0.CO;2-N","volume":"79","author":"R Lazova","year":"1997","unstructured":"Lazova R, Moynes R, May D, Scott G. LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma. Cancer. 1997;79:2115\u201324.","journal-title":"Cancer"},{"key":"560_CR17","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","volume":"343","author":"H D\u00f6hner","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Eng J Med. 2000;343:1910\u20136.","journal-title":"N Eng J Med."},{"key":"560_CR18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3109\/10428194.2011.631638","volume":"53","author":"M Seiffert","year":"2012","unstructured":"Seiffert M, Dietrich S, Jethwa A, Glimm H, Lichter P, Zenz T. Exploiting biological diversity and genomic aberrations in chronic lymphocytic leukemia. Leuk Lymphoma. 2012;53:1023\u201331.","journal-title":"Leuk Lymphoma"},{"key":"560_CR19","unstructured":"J\u00e4ger U, Shehata M, Heintel D, et al. Genetics in chronic lymphocytic leukaemia: impact for prognosis and treatment decisions. Hematology education: the education program for the annual congress of the European Hematology Association. 2007;1:115\u2013121."},{"key":"560_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.leu.2404457","volume":"21","author":"P Ghia","year":"2007","unstructured":"Ghia P, Stomatopoulos K, Belessi C, et al. European Research Initiative on CLL: ERIC recommendations in IGVH gene mutational status analysis in chronic lymphocytic leukemia [editorial]. Leukemia. 2007;21:1\u20133.","journal-title":"Leukemia"},{"key":"560_CR21","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1091\/mbc.E05-04-0327","volume":"16","author":"S Becker-Herman","year":"2005","unstructured":"Becker-Herman S, Arie G, Medvedovsky H, Kerem A, Shachar I. CD74 is a member of the regulated intramembrane proteolysis-processed protein family. Mol Biol Cell. 2005;16:5061\u20139.","journal-title":"Mol Biol Cell"},{"key":"560_CR22","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.4049\/jimmunol.0904149","volume":"184","author":"I Binsky","year":"2010","unstructured":"Binsky I, Lantner F, Grabovsky V, et al. TAp63 regulates VLA-4 expression and chronic lymphocytic leukemia cell migration to the bone marrow in a CD74-dependent manner. J Immunol. 2010;184:4761\u20139.","journal-title":"J Immunol."},{"key":"560_CR23","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1182\/blood-2005-11-4334","volume":"107","author":"D Starlets","year":"2006","unstructured":"Starlets D, Gore Y, Binsky I, et al. Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood. 2006;107:4807\u201316.","journal-title":"Blood"},{"key":"560_CR24","doi-asserted-by":"crossref","first-page":"13408","DOI":"10.1073\/pnas.0701553104","volume":"104","author":"I Binsky","year":"2007","unstructured":"Binsky I, Haran M, Starlets D, et al. IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival. Proc Natl Acad Sci USA. 2007;104:13408\u201313.","journal-title":"Proc Natl Acad Sci USA"},{"key":"560_CR25","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1182\/blood-2004-03-0890","volume":"104","author":"R Stein","year":"2004","unstructured":"Stein R, Qu Z, Cardillo TM, et al. Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies. Blood. 2004;104:3705\u201311.","journal-title":"Blood"},{"key":"560_CR26","doi-asserted-by":"crossref","first-page":"R54","DOI":"10.1186\/ar3767","volume":"14","author":"D Fr\u00f6lich","year":"2012","unstructured":"Fr\u00f6lich D, Bla\u00dffeld D, Reiter K, et al. The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression. Arthritis Res Ther. 2012;14:R54.","journal-title":"Arthritis Res Ther."},{"key":"560_CR27","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1182\/blood-2007-04-087486","volume":"110","author":"F Lantner","year":"2007","unstructured":"Lantner F, Starlets D, Gore Y, et al. CD74 induces TAp63 expression leading to B-cell survival. Blood. 2007;110:4303\u201311.","journal-title":"Blood"},{"key":"560_CR28","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1074\/jbc.M703265200","volume":"283","author":"Y Gore","year":"2008","unstructured":"Gore Y, Starlets D, Maharshak N, et al. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J Biol Chem. 2008;283:2784\u201392.","journal-title":"J Biol Chem"},{"key":"560_CR29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2141.2009.07625.x","volume":"145","author":"Y Souwer","year":"2009","unstructured":"Souwer Y, Chamuleau ME, van de Loosdrecht AA, et al. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival. Br J Haematol. 2009;145:334\u201343.","journal-title":"Br J Haematol"},{"key":"560_CR30","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.4049\/jimmunol.0902566","volume":"185","author":"M Gordin","year":"2010","unstructured":"Gordin M, Tesio M, Cohen S, et al. C-Met and its ligand hepatocyte growth factor\/scatter factor regulate mature B cell survival in a pathway induced by CD74. J Immunol. 2010;185:2020\u201331.","journal-title":"J Immunol."},{"key":"560_CR31","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.3748\/wjg.v16.i26.3258","volume":"16","author":"N Maharshak","year":"2010","unstructured":"Maharshak N, Cohen S, Lantner F, et al. CD74 is a survival receptor on colon epithelial cells. World J Gastroenterol. 2010;16:3258\u201366.","journal-title":"World J Gastroenterol"},{"key":"560_CR32","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2007-05-092882","volume":"112","author":"LZ Rassenti","year":"2008","unstructured":"Rassenti LZ, Jain S, Keating MJ, et al. Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood. 2008;112:1923\u201330.","journal-title":"Blood"},{"key":"560_CR33","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.3748\/wjg.15.2855","volume":"15","author":"EJ Beswick","year":"2009","unstructured":"Beswick EJ, Reyes VR. CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract. World J Gastroenterol. 2009;15:2855\u201361.","journal-title":"World J Gastroenterol"},{"key":"560_CR34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/smim.2001.0338","volume":"14","author":"D Cantrell","year":"2002","unstructured":"Cantrell D. Protein kinase B (Akt) regulation and function in T lymphocytes. Semin Immunol. 2002;14:19\u201326.","journal-title":"Semin Immunol"},{"key":"560_CR35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.coi.2004.03.014","volume":"16","author":"DA Fruman","year":"2004","unstructured":"Fruman DA. Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling. Curr Opin Immunol. 2004;16:314\u201320.","journal-title":"Curr Opin Immunol"},{"key":"560_CR36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1215\/S1152851704001061","volume":"7","author":"DJ Brat","year":"2005","unstructured":"Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol. 2005;7:122\u201333.","journal-title":"Neuro Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0560-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-013-0560-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-013-0560-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T05:50:58Z","timestamp":1562910658000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-013-0560-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,10]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["560"],"URL":"https:\/\/doi.org\/10.1007\/s12032-013-0560-5","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,10]]},"article-number":"560"}}